ARVN

NASDAQ open

Arvinas

6.52 USD
▼-0.22-3.26%
盘后 6.96 0.00%
2026-11-20
市值
$423.03M
市盈率
58.42
EPS
-0.15
股息率
—
52 周区间
6.33 – 14.51
成交量
599.73K
Beta
1.80
目标价
14.00
52W 低 6.3352W 高 14.51
价格走势

公司简介

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body’s own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing clinical development programs, including ARV-102, a leucine-rich repeat kinase 2 (LRRK2) protein for the treatment of neurodegenerative diseases, such...